Logo

CatRio.com.br

Programa de Treinamento em
Hemodinâmica e Cardiologia Intervencionista


Módulo III A
Intervenções Coronárias: materiais, estratégias e técnicas

Palestrante

Os Stents

Dr. Bernardo Amorim
31 Julho 2012 ~ 88 min
* Atualização em 2016

Vídeos
Disponíveis em tela cheia nos controles de reprodução.


What is Angioplasty and Stent?
Animação - Cortesia da Mayo Clinic
Standard YouTube license, 2012 ~ 1min

Angioplastia com Stent
Demonstração angiográfica
Standard YouTube license, 2012 ~ 2min

Referências

― Livros

Kirtane AJ, Stone GW. Coronary stenting. In Moscucci M. editor.
Grossman & Baim's: cardiac catheterization, angiography and intervention. Philadelphia: Lippincott Williams & Wilkins; 2013. 8th ed.
ISBN/ISSN: 9781451127409. Disponível em: http://www.lww.com/Product/9781451127409

Garg S, Rabër L, Serruys PW, Windeker S. Coronary artery stents. In Eeckhout E, Serruys PW, Wijns W, et al. editors.
Percutaneous interventional cardiovascular medicine: The PCR-EAPCI Textbook. Toulouse : Europa Organization; 2012.
ISBN: 978-2-913628-57-1. ISBN: 978-2-913628-67-0 (web edition). Disponível em: http://www.pcronline.com/eurointervention/textbook/pcr-textbook

Serruys PW, Onuma Y, Lafont A, et al. Bioresorbable scaffolds. In Eeckhout E, Serruys PW, Wijns W, et al. editors.
Percutaneous interventional cardiovascular medicine: The PCR-EAPCI Textbook. Toulouse : Europa Organization; 2012.
ISBN: 978-2-913628-57-1. ISBN: 978-2-913628-67-0 (web edition). Disponível em: http://www.pcronline.com/eurointervention/textbook/pcr-textbook

Slavin L, Tobis JM. In-stent restenisis. In Kern JM, Berger PB, Block PC, et al. editors.
SCAI: Interventional cardiology board review book. Philadelphia: Lippincott Williams & Wilkins; 2007. ISBN-13: 978-0-7817-6197-0 / ISBN-10: 0-7817-6197-2

― Periódicos

Nakamura S, Hall P, Gaglione A, et al. High pressure assisted coronary stent implantation accomplished without intravascular ultrasound guidance and subsequent anticoagulation. J Am Coll Cardiol. 1997; 29(1):21-7.

Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.
N Engl J Med. 2002; 346:1773-80.

Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.
J Am Coll Cardiol. 2006; 48(1):193-202.

Mauri L, Hsieh W-h, Massaro JM, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents.
N Engl J Med 2007; 356:1020-9.

Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions.
Circulation. 2007; 115:2344-51.

Bangalore S, Kumar S, Fusaro M, et al. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117,762 patient-years of follow-up from randomized trials. Circulation. 2012; 125:2873-91.

Serruys PW, Morice M-C, Kappetein AP, et al. The SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961-72.

Morice M-C, Serruys PW, Kappetein AP, et al. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy between percutaneous coronary intervention with TAXUS and cardiac surgery (SYNTAX) trial. Circulation. 2010; 121:2645-53.

Stone GW, Parise H, Witzenbichler B, et al. Selection criteria for drug-eluting versus bare-metal stents and the impact of routine angiographic follow-up:
2-year insights from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
J Am Coll Cardiol. 2010; 56:1597-604.

Stone GW, Rizvi A, Newman W, et al. The SPIRIT IV Investigators. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease.
N Engl J Med 2010;362:1663-74.

Serruys PW, Silber S, Garg S, et al. Comparison of zotarolimus-eluting and everolimus-eluting coronary stents.
N Engl J Med 2010;363:136-46.

Stefanini GG, Kalesan B, Serruys PW, et al. Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial. Lancet 2011; 378: 1940–8.

Abizaid A, Costa Jr JR. New drug-eluting-stents: an overview on biodegradable and polymer-free next-generation stent systems.
Circ Cardiovasc Interv. 2010; 3:384-93.

Serruys PW, Onuma Y, Ormistron JA, et al. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes. Circulation. 2010; 122:2301-12.

Serruys PW, Onuma Y, Dudek D, et al. Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes. J Am Coll Cardiol 2011;58:1578–88.

mobiletilt
Em dispositivos móveis este site é melhor visualizado em telas no modo paisagem.